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ABSTRACT
Appropriate, rapid and reliable laboratory tests are essential for the diagnosis and optimal antibiotic
therapy of acute bacterial meningitis. Broad-range bacterial PCR, combined with DNA sequencing, was
compared with culture-based methods for examining cerebrospinal fluid (CSF) samples from patients
with suspected meningitis. In total, 345 CSF specimens from 345 patients were analysed, with acute
community-aquired bacterial meningitis being diagnosed in 74 patients. The CSF of 25 patients was
positive by both PCR and culture; 26 patients had CSF specimens positive by PCR only, and 14 patients
had specimens positive by culture only. The sensitivity of PCR and culture for clinically relevant
meningitis was 59% (44 / 74) and 43% (32 / 74), respectively, while the specificity was 97% (264 / 271)
and 97% (264 / 271), respectively. The commonest bacterial rRNA gene sequences detected by PCR only
were those of Streptococcus pneumoniae and Neisseria meningitidis (n = 12). PCR failed to detect the
bacterial rRNA gene in seven specimens from patients with symptoms compatible with acute bacterial
meningitis. Overall, the results demonstrated that PCR in conjunction with sequencing may be a useful
tool in the diagnosis of bacterial meningitis. PCR is particularly useful for analysing CSF from patients
who have been treated with antibiotics before lumbar puncture.
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INTRODUCTION
Acute bacterial meningitis is a rapidly progress-
ing serious disease with high morbidity and
mortality if treated incorrectly. Meningitis is
usually suspected on the basis of the clinical
presentation of the patient and the finding of
pleocytosis with dominance of polymorpho-
nuclear cells in the cerebrospinal fluid (CSF) at
lumbar puncture. Adequate treatment requires
rapid detection and identification of the bacteria,
as permanent neurological sequelae (e.g., hearing
loss, mental retardation, seizures and behavioural
changes) may occur in up to 50% of survivors.
Current diagnostic methods, i.e., direct microsco-
py and culture, may be insufficient in certain
circumstances, and results from culture are com-
monly not available for at least 24–48 h. Some
patients receive antibiotics before lumbar punc-
ture, resulting in negative CSF cultures, and
meningitis may also be caused by fastidious or
slow-growing microorganisms that are difficult to
detect by culture. Rapid diagnosis of the aetiolo-
gical agent is also particularly important, for
epidemiological reasons, in cases of meningococ-
cal disease, where secondary cases are not
uncommon.
During the last two decades, PCR-based
assays for providing an early and accurate
diagnosis of bacterial meningitis have become
available [1–7]. Broad-range bacterial PCR is
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based on the use of primers that recognise
conserved regions of the gene coding for 16S
rRNA. The resulting amplified rDNA also con-
tains species-specific variable regions that pro-
vide a reliable basis for estimating phylogenetic
relationships among bacteria [8]. Detection of
the 16S rRNA gene can be used to indicate the
presence of bacteria in specimens from usually
sterile locations, with the precise bacterial spe-
cies being identified by subsequent sequencing.
The present study describes a PCR strategy for
the general detection of bacteria in CSF speci-
mens, followed by cycle sequencing to identify
the bacterial species involved.
PATIENTS AND METHODS
Patients
All CSF samples sent for culture to the Bacteriological
Laboratory, Sahlgrenska University Hospital, Go¨teborg, Swe-
den and two adjacent local laboratories (NU-sjukva˚rden,
Uddevalla and SA¨S, Bora˚s) in the same county during a
4-year period (1999–2002) were considered eligible for the
study if the total CSF white blood cell (WBC) count was
‡10 · 106 / L, indicating meningeal inflammation. The data
concerning CSF WBC counts were obtained directly from the
Department of Clinical Chemistry. Only the first CSF sample
from each patient was included. Acute bacterial meningitis
was defined as meningitis caused by either Neisseria menin-
gitidis, Streptococcus pneumoniae, Haemophilus influenzae,
Listeria spp., Gram-negative bacilli, streptococci or sta-
phylococci, as verified by culture from CSF or blood,
and / or clinical signs, e.g., headache, fever and meningis-
mus, compatible with bacterial meningitis. Samples from
patients with nosocomial central nervous system (CNS)
infections or inflammations, defined as an onset of symp-
toms ‡3 days following hospitalisation (i.e., shunt infections
and post-operative CNS infections), were not included in
this study.
Medical records of all patients included in the study were
reviewed retrospectively for a final diagnosis, predisposing
factors, treatment and outcome by one of the authors (LD).
Final diagnoses were: acute community-acquired bacterial
meningitis (n = 74); aseptic meningitis of suspected viral
origin (n = 102); encephalitis (n = 22); Lyme neuroborreliosis
with meningitis (n = 78); Mycoplasma meningoencephalitis
(n = 7); mycobacterial meningitis (n = 4); helmininthic men-
ingitis (n = 1); cryptococcal meningitis (n = 1); parainfectious
meningeal inflammation (CNS abscesses) (n = 14); non-infec-
tious meningeal inflammatory reaction (n = 37); and malig-
nancy with meningeal involvement (n = 5). The relevance of
the PCR findings and bacterial cultures to the final diagnosis
was evaluated and compared with the clinical findings and
other laboratory results.
The study included 345 CSF samples from 345 patients
(51% female) with a CSF WBC count ‡10 · 106 / L. The
median age of the patients was 34 years (range 1 day-
91 years), and 72 patients had severe underlying conditions,
of which the most common were pre-term delivery (n = 24),
malignant disease (n = 16), diabetes mellitus (n = 13), alcohol
abuse (n = 8) and renal insufficiency (n = 3).
Preparation of specimens for PCR
All PCR analyses were performed at the Go¨teborg laboratory.
CSF samples (50 lL - 1.5 mL) were centrifuged at 12 000 g for
20 min, after which DNA was extracted from the pellet with a
bacterial DNA preparation kit (Roche, Stockholm, Sweden),
used according to the manufacturer’s instructions.
DNA amplification techniques
The primers used to amplify a segment of the 16S rRNA gene
were as described previously. Forward primer SSU1 [9],
5¢-CGGCAGGCCTAACACATGCAAGTCG, and reverse
primer 806R [10], 5¢-GGACTACCAGGGTATCTAAT, are
complementary to conserved regions in the 5¢ region of the
16S rRNA gene, producing a fragment of c. 766 bp (nucleotide
positions 41–806 in Escherichia coli [11]).
PCR mixtures contained 50 mM Tris-HCl, pH 8.0, bovine
serum albumin 0.5 mg / mL, 4 mM MgCl2, 100 mM each
dNTP, 2 U of Taq DNA polymerase (Applied Biosystems,
Stockholm, Sweden) and 0.5 lM each primer (CyberGene,
Huddinge, Sweden). Reaction mixtures were illuminated
with UV light at 312 nm (8 W) for 10 min in the reaction
tubes (40-lL aliquots) to eradicate any DNA contaminating
the mastermix, after which 10 lL of DNA extracted from the
clinical specimen was added. Amplification was performed
using a DNA Thermal Cycler 2400 (Applied Biosystems),
with 40 cycles of 15 s at 94C, 30 s at 55C and 1 min at
72C, followed by 10 min at 72C. Aliquots (15 lL) of PCR
products were separated in agarose 2% w / v gels stained
with ethidium bromide, and compared with the amplicon
generated from Staphylococcus aureus. DNA bands of the
expected size (766 bp) were cut from the gel, purified with a
Qiaquick Gel Extraction kit (Qiagen, Go¨teborg, Sweden) and
subjected to cycle sequencing using the ABI PRISM Big Dye
Terminator Cycle Sequencing Ready Reaction kit, v.1.1
(Applied Biosystems). The sequencing reaction products
were analysed using an ABI PRISM 310 Genetic Analyser
(Applied Biosystems).
After DNA sequence editing, the GenBank BLAST program
was used for sequence comparisons [12]. The sequences
obtained from patient specimens matched sequences in the
database, producing significant alignments and providing a
BLAST result, score bits and E-value, indicating the probability
that the match observed was not consistent with chance. Weak
PCR signals giving BLAST similarity results of <97% were
considered to be negative.
Analytical sensitivity of PCR
Strep. pneumoniae, Staph. aureus and E. coli cultures were dilut-
ed ten-fold in sterile phosphate-buffered saline and viable
counts were determined. The bacteria were then added to CSF
(culture- and PCR-negative) to determine the analytical
sensitivity of the assay.
In total, 105 clinical isolates of a wide variety of Gram-
positive and Gram-negative bacteria isolated from CSF or
blood cultures in the Go¨teborg laboratory were used to
confirm that the primers detected bacteria associated with
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bacterial meningitis or sepsis. The primers also amplified DNA
from Chlamydophila pneumoniae and Mycoplasma pneumoniae.
These isolates are available from the Culture Collection of the
University of Go¨teborg (http://www.ccug.se).
Culture
CSF samples were submitted for routine bacterial culture and
chemistry [5]. Other diagnostic procedures, depending on the
clinical circumstances, included CSF cultures for mycobacteria
and fungi, CSF cytology and protein electrophoresis, blood
cultures, serological tests for Mycoplasma, Borrelia and Toxo-
plasma, and serological tests and / or PCRs specific for neuro-
tropic viruses, e.g., herpes simplex virus, varicella-zoster
virus and tick-borne encephalitis virus, according to the
clinicians’ requests. These additional diagnostic procedures
were not performed systematically for all samples, and only
culture results for rapidly growing aerobic and anaerobic
bacteria were included in the comparison with PCR and
sequencing. The sensitivity of PCR vs. bacterial culture was
compared using McNemar’s test. For the subgroup treated
with antibiotics, Fisher’s exact test was used.
RESULTS
PCR-positive samples
The analytical sensitivity of the PCR assay
was 10 CFU / mL for Strep. pneumoniae, and
1 · 103 CFU / mL for Staph. aureus and E. coli. Of
345 clinical specimens, 25 (7%) were positive
by both PCR and culture (Table 1). The PCR
and culture results for the CSF specimens were con-
firmed by culture of blood or samples from other
sterile locations for 17 of these 25 patients.
Bacterial DNA was amplified and sequenced
from culture-negative CSF samples from 26
patients (Table 2). In six cases, DNA from
Strep. pneumoniae was identified, with the pneu-
mococcal aetiology being supported by the isola-
tion of this organism from blood in five of these
six cases. DNA from N. meningitidis was identi-
fied in CSF from six patients, with growth of this
organism from blood of one of the patients. Of
the remaining 14 PCR-positive, culture-negative
samples, the blood culture and CSF PCR results
were concordant in four cases. DNA from
Streptococcus agalactiae was identified in one
sample. Two samples that were PCR-positive
for Staphylococcus haemolyticus and Staphylococcus
epidermidis, respectively, probably represented
contaminants, since other well-known pathogens
were isolated from blood cultures of these
patients. PCR results for another five patients
were also considered to represent contamination,
as two patients had clinical and serological
indications of Lyme neuroborreliosis, one had
M. pneumoniae encephalitis, and two had viral
encephalitis. Finally, DNA from Fusobacterium
and Granulicatella, respectively, was amplified
from two patients with clinical and laboratory
signs of bacterial meningitis, with very high CSF
Table 1. Bacteria detected by both
PCR and culture in cerebrospinal
fluid (CSF) from 25 patients with
acute bacterial meningitis
Bacteria in CSF
Same result from
culture of blood or
other sterile site
Patient
age/gender
CSF leukocytes,
poly/mono
(· 106 / L)
Antibiotic treatment
before sampling
Streptococcus pneumoniae Yes 55 years / F 90 / 113 No
Streptococcus pneumoniae Yes 43 years / F 146 / 16 No
Streptococcus pneumoniae Yes 64 years / M 6400 / NA No
Streptococcus pneumoniae Yes 58 years / F 81 / 32 No
Streptococcus pneumoniae Yes 3 years / M 409 / 97 No
Streptococcus pneumoniae Yes 51 years / F 142 / 174 Cefotaxime IV
Streptococcus pneumoniae Not done 56 years / F 3225 / 410 No
Streptococcus pneumoniae Yes 56 years / M 16600 / 3700 Fenoximethylpenicillin PO
Streptococcus pneumoniae Yes 41 years / F 3480 / 240 No
Streptococcus pneumoniae Not done 85 years / M 5350 / 150 No
Neisseria meningitidis Negative 16 years / F 2295 / 156 No
Neisseria meningitidis Yes 5 months / F 900 / 676 No
Neisseria meningitidis Yes 7 months / F NA / 3000 No
Neisseria meningitidis Yes 15 years / F 117 / 40 Cefotaxime IV
Neisseria meningitidis Not done 10 years / M 4380 / NA No
Neisseria meningitidis Yes 14 years / F 11200 / 1500 No
Haemophilus influenzae Yes 76 years / F 2720 / 100 No
Haemophilus influenzae Yes 1 month / F 1700 / 620 No
Haemophilus influenzae No 29 years / M 5700 / 2500 Cefadroxil PO
Listeria monocytogenes No 59 years / M 2074 / 209 Ampicillin IV
Listeria monocytogenes Not done 59 years / F 810 / 125 No
Staphylococcus aureus Yes 84 years / M 1280 / 340 Cloxacillin IV,
fusidic acid PO,
cefuroxime IV
Staphylococcus aureus Yes 43 years / M 630 / 90 No data
Streptococcus pyogenes Yes 36 years / M 304 / 122 No
Citrobacter koseri Not done 2.5 months / M 2500 / 700 Cefotaxime IV
M, male; F, female; NA, not available; IV, intravenous; PO, oral.
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WBC counts, but there were no other findings
supporting the significance of these DNA ampli-
fication results.
PCR-negative samples
Bacteria were detected by culture from 14 CSF
specimens, but no bacterial DNA was detected by
PCR (Table 3). The culture results were considered
to be clinically relevant in seven cases, as well-
known pathogens were isolated (Staph. aureus,
Listeria monocytogenes and Strep. pneumoniae) and
no other causes of CNS infection were demonstra-
ted. In the remaining seven patients, the organisms
isolated from CSF were probably contaminants (six
isolates of coagulase-negative staphylococci and
one of Ralstonia pickettii) and other causes of CNS
infection were found (Table 3).
Bacteria were identified neither by PCR nor
culture in 280 CSF specimens. In seven cases, both
methods probably failed to detect an aetiological
agent of bacterial meningitis, as these patients had
clinical and laboratory findings suggestive of
bacterial meningitis, and a relevant pathogen
was isolated from blood culture (Staph. aureus,
n = 4; E. coli, n = 2; H. influenzae, n = 1).
Seventy-eight patients with a negative PCR
result had Borrelia meningitis, verified by demon-
stration of Borrelia antibodies in CSF or by
significant increases in Borrelia antibodies in
paired sera. Thus, 78 (23%) of 345 patients had
Lyme neuroborreliosis, 75 with a negative PCR
and culture, one with a positive culture consid-
ered to be a contaminant, and two with positive
PCR results caused by contaminating bacteria
(Tables 1 and 2). Four patients with negative PCR
and culture results had M. pneumoniae meningo-
encephalitis, verified by detection of specific IgM
antibodies in serum. As mentioned above (Ta-
bles 1 and 2), another three patients had Myco-
plasma meningoencephalitis, with signs of
contaminating bacteria according to culture or
PCR. Three patients had CSF specimens positive
for Mycobacterium tuberculosis, and one patient
was positive for atypical mycobacteria.
Viral CNS infection was suspected or verified
in 124 patients; 102 of these patients had viral
meningitis and 22 had signs of encephalitis
Table 2. Bacteria detected by PCR only in cerebrospinal fluid (CSF) from 26 patients
Bacterial DNA in CSF
Same result from
culture of blood or
other sterile site
Patient
age/gender
CSF leukocytes
poly/mono
(· 106 / L)
Antibiotic
treatment
before sampling Final diagnosis
Clinically relevant finding
Streptococcus pneumoniae Negative 42 years / F 3160 / 800 Amoxyclav PO BM
Streptococcus pneumoniae Yes 50 years / F Not available No BM
Streptococcus pneumoniae Yes 78 years / M 3330 / Not available Cefotaxime IV BM
Streptococcus pneumoniae Yes 91 years / M 3540 / 760 Cefuroxime IV BM
Streptococcus pneumoniae Yes 47 years / F 786 / 243 Cefotaxime IV BM
Streptococcus pneumoniae Yes 61 years / F 2 / 6 Cefuroxime IV BM
Neisseria meningitidis Yes 36 years / M 3560 / 1780 No BM
Neisseria meningitidis Negative 6 months / F 9 / 23 No BM
Neisseria meningitidis Negative 57 years / M 840 / 2260 No BM
Neisseria meningitidis Negative 23 years / M 9000 / 900 Cefotaxime IV BM
Neisseria meningitidis Not available 29 years / F 7300 / 600 Cefotaxime IV BM
Neisseria meningitidis No 15 years / F 5510 / 1250 Cefuroxime IV BM
Escherichia coli Yes 73 years / F 1719 / 620 Cefuroxime IV BM
Fusobacterium necrophorum No 68 years / M 5500 / 2300 Cefuroxime IV BM
Granulicatella adiacens No 61 years / F 800 / 3800 Cefotaxime +
ampicillin IV
BM
Klebsiella pneumoniae Yes 35 years / M 2310 / 360 Amoxyclav PO BM
Streptococcus agalactiae Negative 87 years / F 1680 / 160 Cefuroxime IV BM
Streptococcus anginosus Yes 65 years / M 124 / 118 Cefuroxime IV Endocarditis septical
emboli to CNS
Streptococcus intermedius Yes 26 years / M 1540 / 200 Cefuroxime IV Spondylitis,
abscess of the psoas muscle,
secondary BM
Finding not clinically relevant
Acinetobacter spp. Not done 8 years / M 151 / 59 No Viral meningitis
Actinomyces spp. Not done 5 years / F 1 / 37 No Neuroborreliosis
Enterococcus spp. Not done 7 years / F 1 / 20 No Neuroborreliosis
Staphylococcus aureus No 10 years / M 56 / 45 Cefotaxime IV Mycoplasma encephalitis
Staphylococcus haemolyticus Cryptococcus 59 years / F 219 / 423 No Cryptococcal meningitis
Staphylococcus epidermidis/ hominis Salmonella 27 years / M 8 / 19 Cefuroxime IV HIV-positive toxoplasmosis
Streptococcus pyogenes No 38 years / M 0 / 20 No Encephalitis of unknown
origin
M, male; F, Female; IV, intravenous; PO, oral; BM, bacterial meningitis; HIV, human immunodeficiency virus; CNS, central nervous system.
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(including seven with tick-borne encephalitis and
five with herpes simplex type 1 encephalitis). One
patient had an eosinophilic meningitis caused by
the helminth Gnathostoma spinigerum. For 56
patients, other reasons existed for high CSF cell
counts, e.g., aseptic systemic inflammatory dis-
eases, parainfectious meningeal reactions (caused
by brain abscesses), malignancies or sudden
infant death syndrome.
Treatment with antibiotics
Of the 25 patients for whom CSF specimens were
positive by both PCR and culture (Table 1), seven
had received empirical antibiotic therapy before
lumbar puncture, i.e., two patients with
Strep. pneumoniae, one with Staph. aureus, one with
N. meningitidis, one with L. monocytogenes, and one
with Citrobacter koseri. The seventh patient, infec-
ted by H. influenzae, was given empirical treatment
with cefadroxil. No information on the possible
use of antibiotics before lumbar puncture was
available for one patient. In contrast, 15 (79%) of 19
culture-negative CSF specimens with clinically
relevant PCR-positive results (Table 2) were from
patients who had received empirical antibiotic
therapy before lumbar puncture, i.e., five of six
patients with Strep. pneumoniae, three of six
patients with N. meningitidis and seven patients
with either Granulicatella adiacens, Klebsiella
pneumoniae, Strep. agalactiae, Streptococcus
anginosus or Streptococcus intermedius.
Sensitivity and specificity
The sensitivity of PCR for detecting bacterial
meningitis was higher than that of culture (59%
(44 of 74) vs. 43% (32 of 74); p <0.05, McNe-
mar’s test) (Table 4). The specificity of PCR was
high (97%; 264 of 271), and was as high as that
of culture, even though virtually all patients
with some kind of meningeal inflammation
were included in the evaluation. If both culture
and PCR were used for detection of bacterial
meningitis, the sensitivity was 69% (51 of 74).
The difference in the sensitivities between PCR
(79%) and culture (45%) among patients treated
with antibiotics was also statistically significant
(p <0.005, Fisher’s exact test).
Table 3. Bacteria detected only by culture in cerebrospinal fluid (CSF) from 14 patients
Bacteria in CSF
Same result from
culture of blood or
other sterile site
Patient
age/gender
CSF leukocyte
poly/mono
(· 106 / L)
Antibiotic treatment
before sampling Final diagnosis
Clinically relevant finding
Staphylococcus aureus Yes 63 years / M 60 / Not available Cefuroxime IV Septicaemia and BM
Staphylococcus aureus
after enrichment
Not done 88 years / F 49 / 12 Cefuroxime IV Probably septicaemia,
meningeal irritation
Staphylococcus aureus Yes 61 years / M 420 / 140 Cefotaxime IV BM
Staphylococcus aureus
after enrichment
No 86 years / M 1100 / 660 Fenoximethyl-penicillin PO BM
Listeria monocytogenes No 84 years / M 646 / 203 No BM
Listeria monocytogenes Not done 28 years / F 1500 / 170 No BM
Streptococcus pneumoniae
after enrichment
No 47 years / F 154 / 678 Fenoximethyl-penicillin PO BM
Finding not clinically relevant
CoNS No 17 years / F 234 / 75 Doxycycline PO Mycoplasma encephalitis
CoNS Not available 41 years / F 6 / 179 No Herpes simplex encephalitis
CoNS No 71 years / M 0 / 14 No Cerebral lymphoma
CoNS No 38 years / F 0 / 20 No Multiple sclerosis, no infection
CoNS No 31 years / M 1293 / 40 No BM, probably not CoNS
CoNS No 32 years / M 2 / 202 No Borrelia
Ralstonia pickettii No 22 years / M 93 / 97 Not available Mycoplasma encephalitis
M, male; F, female; IV, intravenous; PO, oral; BM, bacterial meningitis; CoNS, coagulase-negative staphylococci.
Table 4. Results of PCR with sequencing and culture in
comparison with clinical diagnosis of acute bacterial
meningitis
Acute bacterial
meningitis
No acute bacterial
meningitisa Total
PCRb
Positive 44 7 51
Negative 30 264 294
Total 74 271 345
Culturec
Positive 32 7 39
Negative 42 264 306
Total 74 271 345
aIncludes 78 patients with a diagnosis of neuroborreliosis and four patients with
mycobacterial infection.
bPCR: sensitivity 59% (44 / 74); specificity 97% (264 / 271); positive predictive value
86% (44 / 51); negative predictive value 91% (264 / 294).
cCulture: sensitivity 43% (32 / 74); specificity 97% (264 / 271); positive predictive
value 82% (32 / 39); negative predictive value 86% (264 / 306).
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DISCUSSION
The present study illustrates both the strengths
and the limitations of broad-range bacterial PCR
for detection of aetiological agents involved in
bacterial meningitis. PCR is rapid and able to
detect low numbers of bacteria in CSF, and non-
viable aetiological agents can be detected despite
the fact that empirical antimicrobial therapy may
have been administered before lumbar puncture.
However, like culture, PCR may also detect
contaminating bacteria and give false-positive
results. DNA from certain bacteria (e.g., Gram-
positive cocci) in CSF seems to be more difficult
to extract and requires additional preparation.
False-negative results may be obtained if more
than one aetiological bacterial species is present.
This may occur particularly in cases of post-
operative or shunt-related CNS infections.
PCR has been a helpful diagnostic tool in
clinical microbiology for more than a decade
[13–15]. With the successful development of new
techniques and instruments, sequencing has
become a relatively quick procedure. However,
the impact of systematic sequencing of non-
cultivable bacteria in a clinical laboratory setting
still needs to be evaluated critically. The results of
PCR and sequencing can be available within 30 h
of the arrival of a specimen in the laboratory.
Isolation of bacteria by culture may require
24–48 h, and may sometimes be hampered by
empirical antibiotic therapy before lumbar punc-
ture.
In the present study, 345 CSF specimens from
345 consecutive patients with signs and symp-
toms of acute meningitis were analysed by culture
and broad-range PCR combined with sequencing
in order to determine the clinical utility of such
techniques for rapid diagnosis and as a guide to
the clinician in making decisions concerning
antimicrobial therapy. The molecular methods
used in this study are faster and more discrimin-
atory than, e.g., hybridisation techniques or tech-
niques using semi-nested PCR or restriction
enzyme digestion instead of sequencing [2,3,16].
Probe-based real-time PCR is the method of
choice when using a multiplex PCR for simulta-
neous detection of different specific target se-
quences. However, real-time PCR does not
appear to offer advantages when performing a
broad-range PCR [7,17,18]; indeed, there may be
disadvantages, including possible cross-reactions
with human DNA and a need for DNA clean-up
before sequencing to avoid any fluorescent inter-
ference.
The present study used conventional PCR
followed by agarose gel electrophoresis in order
to visualise and selectively purify specific ampli-
cons. In this way, irrelevant PCR products, e.g.,
primer dimers or products originating from
human DNA, could be avoided and good-quality
DNA could be obtained for sequencing. Xu et al.
[5] showed that the combination of broad-range
conventional PCR and sequencing was compar-
able to specific real-time PCR for the detection of
N. meningitidis. Real-time PCR using specific
primers may complement broad-range PCR for
detection of the most common pathogens causing
bacterial meningitis, which would circumvent
otherwise necessary sequencing. However,
culture will continue to be required to facilitate
susceptibility testing.
In addition to detecting the 25 bacterial species
identified by culture, PCR and sequencing detec-
ted another 19 culture-negative cases of acute
bacterial meningitis. Of these, 15 patients had
received antibiotics before lumbar puncture, con-
firming that PCR amplification may detect non-
viable bacteria. This may also be the reason why
several cases of bacterial meningitis caused by
Strep. pneumoniae were detected only by PCR, as
pneumococci have a tendency to autolyse in
culture media. In contrast, of the 25 patients with
CSF specimens positive by both PCR and culture,
only five had been given antibiotics before lumbar
puncture.
Gran. adiacens and Fusobacterium necrophorum
were identified only by PCR and sequencing in
CSF samples from two patients. These two organ-
isms are known to be fastidious and may be
difficult to detect by culture. These two patients
showed symptoms of acute bacterial meningitis;
no other bacteria were detected, and no other
underlying diseases were present. There are
several reports of Fusobacterium as a cause of
bacterial meningitis [19,20], but reports describing
Granulicatella as a causative agent are rare [21],
perhaps because detection systems have not been
sufficiently sensitive. It is not always possible to
state with certainty whether an organism of low
virulence is a relevant pathogen or a contaminant.
The detection of DNA from Gran. adiacens and
other streptococci-like bacteria in the present
study should therefore be regarded with caution.
884 Clinical Microbiology and Infection, Volume 13 Number 9, September 2007
 2007 The Authors
Journal Compilation  2007 European Society of Clinical Microbiology and Infectious Diseases, CMI, 13, 879–886
The PCR technique failed to identify seven
cases of bacterial meningitis; in two of these cases,
L. monocytogenes was identified by culture. It is
known that Listeria produces symptoms of
bacterial meningitis even when present only in
low (40–400 CFU / mL) numbers in CSF [22]. This
could explain why PCR failed to identify the
bacteria in these specimens, as also reported in
two other studies [6,23]. A nested or semi-nested
PCR might improve the sensitivity by up to
100-fold, which would help to solve this problem
[23,24], but the laboratory would need to be
informed in advance by the clinician that Listeria
infection was suspected.
During the present study it became apparent
that the method for preparing DNA from a
diversity of bacterial species, many of which are
encapsulated, required further improvement. All
specimens prepared for the detection of bacterial
DNA of unknown bacterial species are now
treated with mutanolysin and lysostaphin to
effectively destroy the cell wall [25,26]. The failure
to detect Staph. aureus by PCR in four CSF
specimens and Strep. pneumoniae in one (Table 3)
might be explained by inadequate extraction of
DNA. One specimen containing Strep. pneumoniae
and two of four specimens containing Staph.
aureus were detected only by culture after culti-
vation in enrichment broth, which probably
reflected low numbers of bacteria in the CSF. In
general, 2 mL of the CSF specimen was used for
culture, and the remainder (often <500 lL) was
used for PCR, which might explain the decreased
sensitivity of the PCR. It is therefore recom-
mended that at least 1 mL of CSF is used for PCR
analysis, even though N. meningitidis was detect-
ed in a volume of c. 50 lL. The importance of the
volume of CSF analysed has not been addressed
adequately in previous studies, which have
usually focused on detection of H. influenzae,
N. meningitidis and Strep. pneumoniae, all of which
are often present in high numbers in the CSF of
patients with meningitis [3,6].
PCR and culture gave concordant negative
results for 280 specimens, of which 261 were
from patients whose final diagnosis was not acute
bacterial meningitis, with high WBC counts being
caused by virus infections or other factors. Sev-
enty-eight of these patients had tick-borne Borrelia
burgdorferi sensu lato meningitis. Detection of
Borrelia spirochaetes in CSF is not possible by
PCR targeted at the 16S rRNA gene of Borrelia
spp. Seven patients had Mycoplasma meningitis
according to serological findings, although no
bacteria were identified in CSF by PCR. Sensitivity
is, to some extent, dependent on the number of
copies of the 16S rRNA gene. As M. pneumoniae has
only one gene coding for 16S rRNA [27], this
organism is more difficult to detect than (e.g.)
E. coli, which has seven copies of the 16S rRNA
gene [28]. An additional eight CSF specimens gave
very weak PCR results, and the subsequent low-
quality DNA sequences resulted in GenBank simi-
larities of <97%. These were considered to be
negative results, as this percentage is the lowest
acceptable similarity for a bacterial isolate to be
identified to a known species [29]. Such identifi-
cations cannot be reported to the clinician as a
reliable result.
It has been suggested previously that PCR can
be used for diagnostic purposes when patients
have been treated with antibiotics, since both
dead and viable microorganisms can be detected
[5,6], and this was confirmed in the present study.
The broad-range PCR described in this study has
been tested with CSF specimens in a clinical
setting for a 3-year period. Following successful
comparisons with laboratory findings and clinical
symptoms, the PCR method is now used in
clinical practice to complement direct microscopy
and culture, especially when patients with sus-
pected bacterial meningitis have been treated
with antibiotics before sampling.
In summary, the present study demonstrated
that broad-range PCR combined with sequencing
may be valuable for diagnosing and identifying
the aetiology of acute community-acquired bac-
terial meningitis. The method is especially useful
with CSF specimens from patients who have been
given empirical antibiotics before the lumbar
puncture. The technique is relatively fast and
may be used routinely. Using ‡1 mL of CSF, the
sensitivity is adequate for the detection of most
bacteria. However, Borrelia, Listeria and Mycoplas-
ma may be present in CSF in low numbers, and
may have few copies of the 16S rRNA gene;
therefore, if these bacteria are suspected, a nested
PCR approach is preferable.
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